NEFL and amyotrophic lateral sclerosis: Notably, a robust decrease in plasma NfL levels was observed in response to delayed intervention with ATH-1105, which remained attenuated for the rest of the study, despite the continued increase in NfL concentrations in the ALS + vehicle group (Figure 8I).